The Effects of Acupuncture on the Natural Pregnancy in Patients With Recurrent Abortion

Sponsor
Jianmei Xia (Other)
Overall Status
Completed
CT.gov ID
NCT05998421
Collaborator
(none)
46
1
2
16.9
2.7

Study Details

Study Description

Brief Summary

Recurrent spontaneous abortion (RSA) is a common pregnancy complication in women of reproductive age and the cause of RSA remains largely unclear. Acupuncture is widely used in clinical practice to treat infertility and abortion. The role of acupuncture in the treatment of infertility is still unclear. The investigators conducted a randomized, prospective, controlled clinical trial to investigate its potential impact on pregnancy outcome. Herein, the investigators not only evaluated the changes in patients' psychological stress before and after treatment but also followed up on pregnancy outcomes. In addition, changes in uterine artery blood flow were observed by ultrasound. Changes in coagulation-related indicators were also detected.

Condition or Disease Intervention/Treatment Phase
  • Procedure: acupuncture
  • Drug: routine aspirin and heparin treatment
N/A

Detailed Description

To better illustrate the effectiveness and mechanism of acupuncture in infertility, especially in RSA patients, the investigators conducted a randomized, prospective, controlled clinical trial to investigate its potential impact on pregnancy outcome. Herein, the investigators not only evaluated the changes in patients' psychological stress before and after treatment but also followed up on pregnancy outcomes. In addition, changes in uterine artery blood flow were observed by ultrasound. Changes in coagulation-related indicators were also detected. The investigators hypothesized that acupuncture could promote and improve pregnancy by improving uterine artery blood flow and relieving patients' anxiety symptoms. To our knowledge, it has never been reported before.

Study Design

Study Type:
Interventional
Actual Enrollment :
46 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Treatment
Official Title:
The Effects of Acupuncture on the Natural Pregnancy in Patients With Recurrent Abortion: a Randomized Prospective Trial
Actual Study Start Date :
Mar 1, 2022
Actual Primary Completion Date :
Mar 1, 2023
Actual Study Completion Date :
Jul 29, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: the drug group (control group)

The patients in the control group accepted routine aspirin and heparin treatment. Two months before pregnancy, 50 mg of aspirin (Chenxin Pharmaceutical, China) was taken orally once a day.

Drug: routine aspirin and heparin treatment
The patients accepted routine aspirin and heparin treatment. Two months before pregnancy, 50 mg of aspirin (Chenxin Pharmaceutical, China) was taken orally once a day.

Experimental: the drug-accompanied-by-acupuncture group (acupuncture group)

The patients in the acupuncture group accepted acupuncture treatment weekly from the second day of menstruation and three times in one cycle.

Procedure: acupuncture
The patients in the acupuncture group accepted acupuncture treatment weekly from the second day of menstruation and three times in one cycle. Seirin 0.2-×30-mm acupuncture needles were used. First, needles were inserted into Shenting (GV 24) and bilateral Benshen (G 13) to relieve uneasiness of mind. Then, they were inserted into Chung wan (cv 12), Qihai (CV6), Guan yuan, chung chi (cv 3), bilateral Guiai (S 29) and Zigong (Extra 16) to recuperate energy. Finally, bilateral Tsusanli (st 36), Yinlingch'uan (sp 9) and San yin chiao (sp 6) were used to soothe the liver and tonify the spleen and kidney. Each acupuncture treatment session lasted 30 minutes, with mostly bilateral needle retention over 20-30 minutes for evens techniques.

Drug: routine aspirin and heparin treatment
The patients accepted routine aspirin and heparin treatment. Two months before pregnancy, 50 mg of aspirin (Chenxin Pharmaceutical, China) was taken orally once a day.

Outcome Measures

Primary Outcome Measures

  1. The effect of acupuncture on pregnancy outcome in patients with recurrent spontaneous abortion [average of 1 year]

    The pregnancy outcome of each patient was followed-up. The outcomes of natural pregnancy include normal clinical pregnancy(intrauterine pregnancy and pregnancy week ≥28) and adverse pregnancy. The latter includes biochemical pregnancy, spontaneous abortion and ectopic gestation.

  2. The change of blood indicators related to blood coagulation function after acupuncture1 [average of half of a year]

    Changes in blood indicators related to blood coagulation function, such as platelet maximum aggregation rate (MAR, inducted by arachidonic acid (AA) and adenosine diphosphate (ADP)), were also detected before and after treatment.

  3. The effect of acupuncture on blood flow impedance in the uterine arteries before and after each treatment cycle [average of half of a year]

    Patients in both groups were scheduled for vaginal ultrasound in the mid luteal phase to monitor the blood flow impedance in the uterine arteries before and after each treatment cycle, measured as the uterine artery (UA) systolic/diastolic (S/D) blood flow ratio.

  4. The effect of acupuncture on patients' mental anxiety status before and after each treatment cycle [average of half of a year]

    Generalized anxiety disorder (GAD-7) was used to assess patients' mental anxiety status. Each item has a score of 0-3, totaling 7 items, with a total score of 0-21. The higher the score, the more severe it becomes.

  5. The change of blood indicators related to blood coagulation function after acupuncture2 [average of half of a year]

    Changes in blood indicators related to blood coagulation function, such as D-dimer (D-D)were also detected before and after treatment.

  6. The change of blood indicators related to blood coagulation function after acupuncture3 [average of half of a year]

    Changes in blood indicators related to blood coagulation function, such as prothrombin time (PT) and activated partial thromboplastin time (APTT), were also detected before and after treatment.

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • had a previous RSA history;

  • had a normal body mass index (BMI) of 18-25 kg/m2;

  • had no acute infection of the abdomen and low back skin;

  • had no history of liver or kidney disease.

Exclusion Criteria:
  • acute infection in the abdomen or lower back

  • planning assisted reproductive technologies (ART) in the next 3 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jianmei Xia Hangzhou Zhejiang China 310006

Sponsors and Collaborators

  • Jianmei Xia

Investigators

  • Principal Investigator: Jianmei Xia, First People's Hospital of Hangzhou

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jianmei Xia, Deputy Chief Physician, First People's Hospital of Hangzhou
ClinicalTrials.gov Identifier:
NCT05998421
Other Study ID Numbers:
  • 2023003
First Posted:
Aug 21, 2023
Last Update Posted:
Aug 21, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 21, 2023